M 228 (Pioglitazone hydrochloride 30 mg (base))
Pill imprint M 228 has been identified as Pioglitazone hydrochloride 30 mg (base).
Pioglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 30 mg (base) is not subject to the Controlled Substances Act.
See also related documents.
Images for M 228 (Pioglitazone hydrochloride 30 mg (base))
- 30 mg (base)
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- hydroxypropyl cellulose
sodium lauryl sulfate
sodium starch glycolate type A potato
Pioglitazone hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...